Hyaluronic Acid Market Analysis by Product (Single Injection, Three Injection, Five Injection), by Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), by Raw Materials (Grade [Pharmaceutical Grade, Cosmetic Grade, Food Grade], Source [Animal based, Non-Animal Based]), and Segment Forecasts to 2024

Published: Aug, 2016 | Pages: 87 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global hyaluronic acid market is expected to reach USD 13.4 billion by 2024, according to a new report by Grand View Research. Factors such as increasing concern in population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact-rendering drivers of this market.

The market is evolving rapidly due to the increasing adoption of aesthetic procedures in both developed and developing regions. The growing geriatric population coupled with growing awareness about antiaging products and aspiration to look healthy and young is fueling the market for all cosmetics. The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base.

The increase in obesity resulting in osteoarthritis and joint pain has boosted the demand for hyaluronic acid injections as treatment. In 2012, approximately 53 million people were diagnosed with osteoarthritis and it is projected that by 2040, the number will grow to 78 million. This can be anticipated as exponential growth in demand for hyaluronic acid injections.

Moreover, mounting number of obese people indicates the growing number of people suffering from orthopedic disorders. There is no permanent cure for these disorders and treatment includes use of pain killers. However, hyaluronic acid-based viscosupplements are seen as a possible cure or at least a better option to joint pain.

Further Key Findings from the Study Suggest:

In 2015, dermal fillers dominated the application segment due to increasing awareness about the available aesthetic procedures and approval of effective products by the FDA. For instance, in 2013, the U.S. FDA approved hyaluronan-based facial fillers to be used in corrective measures, filling fine lines, and antiaging procedures. These dermal fillers constitute a large share in these procedures and witnessed 8% growth in the year 2014. Cosmetic surgeries market is booming with approximately 14 million minimally invasive procedures being performed every year.

Pharmaceutical-grade hyaluronan holds the largest share in terms of raw material used for products. It is available in a wide range of molecular weights and manufacturers also provide customized hyaluronic acid, especially for research purposes.

In 2015, non-animal based hyaluronan held the largest share of the source segment. It is extracted from recombinant bacteria and has uniform molecular weight; therefore, it is preferred for research purposes. Furthermore, non-animal based hyaluronic acid is preferred as the raw material for the production of food supplements. It eliminates the risk of cross-contamination and the varied molecular weight does not affect the quality of the products.

In 2015, North America dominated the market with a revenue share of over 40%. In 2009, the first viscosupplement Synvisc-One, by Genzyme Corporation, was approved in the U.S. and gained quick popularity owing to its efficacy and ease of use.

Increase in understanding of aging processes coupled with the interest in dermal fillers boosted the demand for antiaging procedures in this region. Presence of market leaders such as Genzyme Corporation and Anika Therapeutics in this region also contributes to fueling customer awareness and acceptance as a result of aggressive marketing strategies of these companies.

Asia Pacific is anticipated to emerge as the fastest growing region during the forecast period. The growing geriatric population in Japan and China provides a large customer base for antiaging products and services. Moreover, Asian population is influenced by western beauty standards and aims for volumized appearance. This has resulted in 14% growth of dermal filler market as compared to the 7% in North America.

Some key participants of the market are Anika Therapeutics, Inc.; Seikagaku Corporation; Galderma S.A.; Sanofi (Genzyme); Salix Pharmaceuticals; Allergan, Inc.; F. Hoffmann-La Roche Ltd., Zimmer Holdings, Inc.; Ferring Pharmaceuticals, Inc.; and Smith & Nephew Plc.

 Table of Content

Chapter 1 Research Methodology
                    1.1 Information Procurement
                    1.2 Data Analysis


Chapter 2 Executive Summary

Chapter 3 Market Snapshot

Chapter 4 Market Variables, Trends and Scope
                    4.1 Market Segmentation and Scope
                         4.1.1 Market driver analysis
                              4.1.1.1 Increasing geriatric population
                              4.1.1.2 Rising awareness and demand of anti-aging products
                              4.1.1.3 Increasing incidence rate of orthopedic and ophthalmic diseases
                         4.1.2 Market restraint analysis
                              4.1.2.1 Side-effects of hyaluronic acid injections
                    4.2 Penetration and Growth Prospects Mapping
                    4.3 Hyaluronic Acid Market PESTEL Analysis
                    4.4 Industry Analysis - Porter’s
                    4.5 Hyaluronic acid competitive landscape
                         4.5.1 Company market share analysis, 2015
                         4.5.2 Competitive landscape: Market position analysis (This segment would provide insights on the performance and position of key players operating in this market based on their product portfolio, segment financial performance, distribution network, regional presence and other strategic initiatives)

Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis
                    5.1 Global Hyaluronic Acid Market: Product Movement Analysis
                    5.2 Single Injection
                         5.2.1 Single injection market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.3 Three injection
                         5.3.1 Three injection market estimates and forecasts, 2013 - 2024 (USD Million)
                    5.4 Five injection
                         5.4.1 Five injection market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 6 Market Categorization 2: Application Estimates & Trend Analysis
                    6.1 Application Movement Analysis & Market Share, 2015 & 2024
                    6.2 Osteoarthritis
                         6.2.1 Osteoarthritis market estimates and forecasts, 2013 - 2024 (USD Million)
                    6.3 Ophthalmic
                         6.3.1 Ophthalmic market estimates and forecasts, 2013 - 2024 (USD Million)
                    6.4 Dermal Fillers
                         6.4.1 Dermal Fillers market estimates and forecasts, 2013 - 2024 (USD Million)
                    6.5 Vesicoureteral Reflux
                         6.5.1 Vesicoureteral Reflux market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 7 Market Categorization 3: Raw Material (by Grade) Estimates & Trend Analysis
                    7.1 Raw Material (by Grade) Movement Analysis & Market Share, 2015 & 2024
                    7.2 Pharmaceutical Grade
                         7.2.1 Pharmaceutical grade hyaluronic acid market estimates and forecasts, 2013 - 2024 (USD Million)
                    7.3 Cosmetic Grade
                         7.3.1 Cosmetic grade hyaluronic acid market estimates and forecasts, 2013 - 2024 (USD Million)
                    7.4 Food Grade
                         7.4.1 Food grade hyaluronic acid market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 8 Market Categorization 4: Raw Material (by Source) Estimates & Trend Analysis
                    8.1 Raw Material (by Source) Movement Analysis & Market Share, 2015 & 2024
                    8.2 Animal based
                         8.2.1 Animal based hyaluronic acid market estimates and forecasts, 2013 - 2024 (USD Million)
                    8.3 Non-animal based
                         8.3.1 Non-animal based hyaluronic acid market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter9 Market Categorization 5: Regional Estimates & Trend Analysis, by Product, Application, & Raw Material
                    9.1 Regional Movement Analysis & Market Share, 2015 & 2024
                    9.2 North America
                         9.2.1 North America hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                         9.2.2 North America hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                         9.2.3 North America hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                         9.2.4 North America hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.2.5 U.S.
                              9.2.5.1 U.S. hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.2.5.2 U.S. hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.2.5.3 U.S. hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.2.5.4 U.S. hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.2.6 Canada
                              9.2.6.1 Canada hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.2.6.2 Canada hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.2.6.3 Canada hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.2.6.4 Canada hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                    9.3 Europe
                         9.3.1 Europe hyaluronic acid market, by product, 2013 - 2024 (USD Million
                         9.3.2 Europe hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                         9.2.3 Europe hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                         9.2.4 Europe hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.3.5 Germany
                              9.3.5.1 Germany hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.3.4.2 Germany hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.3.5.3 Germany hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.3.5.4 Germany hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.3.6 UK
                              9.3.6.1 UK hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.3.6.2 UK hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.3.6.3 UK hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.3.6.4 UK hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.3.7 France
                              9.3.7.1 France hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.3.7.2 France hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.3.7.3 France hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.3.7.4 France hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.3.8 Italy
                              9.3.8.1 Italy hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.3.8.2 Italy hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.3.8.3 Italy hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.3.8.4 Italy hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.3.9 Russia
                              9.3.9.1 Russia hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.3.9.2 Russia hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.3.9.3 Russia hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.3.9.4 Russia hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                    9.4 Asia Pacific
                         9.4.1 Asia Pacific hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                         9.4.2 Asia Pacific hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                         9.4.3 Asia Pacific hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                         9.4.4 Asia Pacific hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.4.5 Japan
                              9.4.5.1 Japan hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.4.5.2 Japan hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.4.5.3 Japan hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.4.5.4 Japan hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.4.6 China
                              9.4.6.1 China hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.4.6.2 China hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.4.6.3 China hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.4.6.4 China hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.4.7 South Korea
                              9.4.7.1 South Korea hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.4.7.2 South Korea hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.4.7.3 South Korea hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.4.7.4 South Korea hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                    9.5 Latin America
                         9.5.1 Latin America hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                         9.5.2 Latin America hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                         9.5.3 Latin America hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                         9.5.4 Latin America hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.5.5 Brazil
                              9.5.5.1 Brazil hyaluronic acid market, by product ,2013 - 2024 (USD Million)
                              9.5.5.2 Brazil hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.5.5.3 Brazil hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.5.5.4 Brazil hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.5.6 Mexico
                              9.5.6.1 Mexico hyaluronic acid market, by product ,2013 - 2024 (USD Million)
                              9.5.6.2 Mexico hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.5.6.3 Mexico hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.5.6.4 Mexico hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                    9.6 Middle East & Africa
                         9.6.1 Middle East & Africa hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                         9.6.2 Middle East & Africa hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                         9.6.3 Middle East & Africa hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                         9.6.4 Middle East & Africa hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)
                         9.6.5 South Africa
                              9.6.5.1 South Africa hyaluronic acid market, by product, 2013 - 2024 (USD Million)
                              9.6.5.2 South Africa hyaluronic acid market, by application, 2013 - 2024 (USD Million)
                              9.6.5.3 South Africa hyaluronic acid market, by raw material (grade), 2013 - 2024 (USD Million)
                              9.6.5.4 South Africa hyaluronic acid market, by raw material (source), 2013 - 2024 (USD Million)

Chapter10 Hyaluronic Acid Reimbursement Outlook
                    10.1 Reimbursement by Product
                         10.1.1 Gel One
                         10.1.2 EUFLEXXA
                         10.1.3 Synvisc-One
                         10.1.4 Supartz
                         10.1.5 Hyalgan
                         10.1.6 Monovisc
                         10.1.7 Orthovisc
                         10.1.8 Juvederm, Emervel, Restylane, Macrolane, Belotero, Filorga,Jalupro, Princess, Teosyal, Stylage, Filorga and others
                    10.2 Reimbursement by Region
                         10.2.1 U.S.
                         10.2.2 Canada
                         10.2.3 China
                         10.2.4 Japan
                         10.2.5 India 
                         10.2.6 Brazil
                         10.2.7 South Africa
                         10.2.8 Europe

Chapter 11 Competitive Landscape
                    11.1 Allergan Inc
                         11.1.1 Company overview
                         11.1.2 Financial performance
                         11.1.3 Product benchmarking
                         11.1.4 Strategic initiatives
                    11.2 Sanofi 
                         11.2.1 Company overview
                         11.2.2 Financial performance
                         11.2.3 Product benchmarking
                         11.2.4 Strategic initiatives
                    11.3 Genzyme Corporation. 
                         11.3.1 Company overview
                         11.3.2 Financial performance
                         11.3.3 Product benchmarking
                         11.3.4 Strategic initiatives
                    11.4 Anika Therapeutics Inc. 
                         11.4.1 Company overview
                         11.4.2 Financial performance
                         11.4.3 Product benchmarking
                         11.4.4 Strategic initiatives
                    11.5 Salix Pharmaceuticals 
                         11.5.1 Company overview
                         11.5.2 Financial performance
                         11.5.3 Product benchmarking
                         11.5.4 Strategic initiatives
                    11.6 Seikagaku Corporation 
                         11.6.1 Company overview
                         11.6.2 Financial performance
                         11.6.3 Product benchmarking
                         11.6.4 Strategic Initiatives
                    11.7 F.Hoffmann-La Roche Ltd.
                         11.7.1 Company overview
                         11.7.2 Financial performance
                         11.7.3 Product benchmarking
                         11.7.4 Strategic initiatives
                    11.8 Galderma S.A
                         11.8.1 Company overview
                         11.8.2 Financial performance
                         11.8.3 Product benchmarking
                         11.8.4 Strategic initiatives
                    11.9 Zimmer Holdings Inc
                         11.9.1 Company overview
                         11.9.2 Financial performance
                         11.9.3 Product benchmarking
                         11.9.4 Strategic initiatives
                    11.10 Smith & Nephew plc
                         11.10.1 Company overview
                         11.10.2 Financial performance
                         11.10.3 Product benchmarking
                         11.10.4 Strategic initiatives
                    11.11 Ferring Pharmaceuticals Inc.
                         11.11.1 Company overview
                         11.11.2 Financial performance
                         11.11.3 Product benchmarking
                         11.11.4 Strategic initiatives
                    11.12 Lifecore Biomedical
                         11.12.1 Company overview
                         11.12.2 Financial performance
                         11.12.3 Product benchmarking
                         11.12.4 Strategic initiatives
                    11.13 HTL Biotechnology
                         11.13.1 Company overview
                         11.13.2 Financial performance
                         11.13.3 Product benchmarking
                         11.13.4 Strategic initiatives
                    11.14 Shiseido
                         11.14.1 Company overview
                         11.14.2 Financial performance
                         11.14.3 Product benchmarking
                         11.14.4 Strategic initiatives
                    11.15 Bloomage Freda Biopharm Co. Ltd
                         11.15.1 Company overview
                         11.15.2 Financial performance
                         11.15.3 Product benchmarking
                         11.15.4 Strategic initiatives
                    11.16 Maruha Nichiro, Inc
                         11.16.1 Company overview
                         11.16.2 Financial performance
                         11.16.3 Product benchmarking
                         11.16.4 Strategic initiatives

List of Tables

TABLE 1 Country Share Estimation
TABLE 2 North America hyaluronic acid market estimates and forecasts, by region, 2013 - 2024 (USD Million)
TABLE 3 North America hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 4 North America hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 5 North America hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 6 North America hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 7 U.S. hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 8 U.S. hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 9 U.S. hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 10 U.S. hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 11 Canada hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 12 Canada hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 13 Canada hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 14 Canada hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 15 Europe hyaluronic acid market estimates and forecasts, by region, 2013 - 2024 (USD Million)
TABLE 16 Europe hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 17 Europe hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 18 Europe hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 19 Europe hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 20 UK hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 21 UK hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 22 UK hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 23 UK hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 24 France hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 25 France hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 26 France hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 27 France hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 28 Germany hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 29 Germany hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 30 Germany hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 31 Germany hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 32 Italy hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 33 Italy hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 34 Italy hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 35 Italy hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 36 Russia hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 37 Russia hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 38 Russia hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 39 Russia hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 40 APAC hyaluronic acid market estimates and forecasts, by region, 2013 - 2024 (USD Million)
TABLE 41 APAC hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 42 APAC hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 43 APAC hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 44 APAC hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 45 South Korea hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 46 South Korea hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 47 South Korea hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 48 South Korea hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 49 China hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 50 China hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 51 China hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 52 China hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 53 Japan hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 54 Japan hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 55 Japan hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 56 Japan hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 57 Latin America hyaluronic acid market estimates and forecasts, by region, 2013 - 2024 (USD Million)
TABLE 58 Latin America hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 59 Latin America hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 60 Latin America hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 61 Latin America hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 62 Brazil hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 63 Brazil hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 64 Brazil hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 65 Brazil hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 66 Mexico hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 67 Mexico hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 68 Mexico hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 69 Mexico hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 70 MEA hyaluronic acid market estimates and forecasts, by region, 2013 - 2024 (USD Million)
TABLE 71 MEA hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 72 MEA hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 73 MEA hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 74 MEA hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)
TABLE 75 South Africa hyaluronic acid market estimates and forecasts, by product type, 2013 - 2024 (USD Million)
TABLE 76 South Africa hyaluronic acid market estimates and forecasts, by application type, 2013 - 2024 (USD Million)
TABLE 77 South Africa hyaluronic acid market estimates and forecasts, by raw material (grade) type, 2013 - 2024 (USD Million)
TABLE 78 South Africa hyaluronic acid market estimates and forecasts, by raw material (source) type, 2013 - 2024 (USD Million)